Skip to content

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

RecruitingNCT01719055
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice

Study details

Official title
A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Conditions
Interventions
  • Device: neurostimulation system
Sponsor
Boston Scientific Corporation
Start date
2012-11-19
Primary completion
2035-05
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Argentina, Australia, Belgium, Canada, Colombia, Denmark, Germany, Israel, Italy, Japan, Netherlands, Spain, Sweden, Switzerland, United Kingdom, United States
Total sites listed
118

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Key Inclusion Criteria: * Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use * Signed a valid, IRB/EC-approved informed consent form * 18 years of age or older Key Exclusion Criteria: * Contraindicated for Boston Scientific neurostimulation system * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Canadian sites (3)

FacilityCityProvince
London Health Sciences CentreLondon
Hopital de Enfant-JesusQuébec
Regina General HospitalRegina
Canadian sites for NCT01719055LondonQuébecRegina
Canadian sites for NCT01719055. 3 mapped locations with coordinates in the registry. Schematic plot, not to scale.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01719055